Financial health
- Operating income covered interest expense 76× in the latest year, up from -21.8× 5 years ago.
7 years of revenue, profit, cash flow and balance-sheet history through FY2025, from SEC filings, in CNY as reported — with a computed, factual read of the trend. Updated Overview →
| FY | Revenue | Net income | Gross M | Op M | ROE | ROA | FCF | Total debt | Cash |
|---|---|---|---|---|---|---|---|---|---|
| 2025 | — | CN¥336M | — | — | 8.4% | 5.6% | -CN¥559M | — | CN¥1.5B |
| 2024 | — | -CN¥8M | — | — | -0.2% | -0.2% | CN¥583M | — | CN¥2.0B |
| 2023 | — | -CN¥156M | — | — | -4.2% | -2.8% | CN¥159M | — | CN¥2.0B |
| 2022 | — | -CN¥2.5B | — | — | -63.6% | -48.9% | CN¥820M | — | CN¥1.7B |
| 2021 | — | -CN¥817M | — | — | -12.7% | -10.9% | -CN¥1.1B | — | CN¥1.4B |
| 2020 | — | -CN¥471M | — | — | 9.0% | -9.0% | -CN¥451M | CN¥402M | CN¥918M |
| 2019 | — | -CN¥705M | — | — | 20.5% | — | -CN¥514M | — | CN¥411M |
See the revenue and net-income charts above for Atrenew Inc.'s multi-year trend.
As of FY2025, Atrenew Inc. reported — of total debt against CN¥1.5B of cash; operating income covered interest expense 76×.
In FY2025, gross margin was —, operating margin —, and net margin —.
All figures are extracted from the company’s SEC EDGAR/XBRL filings — its annual and interim reports, in CNY as reported (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (annual and interim filings, reported in CNY) · prices EOD (Databento), split-adjusted; price return — dividends not reinvested · growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price against the latest annual filing. Informational only — not investment advice.